DWS

DWS is a prominent investment management firm based in Germany, founded in 1975. It offers a wide range of investment products and services to both institutional and private investors. With approximately EUR 704 billion in assets under management, DWS provides a diverse portfolio that includes active fixed income, multi-asset, equity, alternatives, and cash investments. The firm also specializes in real estate and direct lending funds. Although DWS was fully owned by Deutsche Bank until 2018, the bank retains a significant stake. The firm's German market is crucial, accounting for about 40% of its assets, while the broader EMEA region contributes to 70%. Institutional clients represent 55% of DWS's overall assets under management, highlighting the firm's strong focus on serving this segment.

Bjorn Jesch

Global Chief Investment Officer and CEO, DWS Switzerland

Blanca Konig

Director, Fixed income Product Development and Strategies

Asoka Woehrmann

CEO and Head of Executive Division

11 past transactions

Red Oak

Debt Financing in 2021
Red Oak Apartment Homes offers something for every budget and lifestyle.

DataLink LLC

Private Equity Round in 2020
DataLink LLC is a healthcare technology company based in Temple Terrace, Florida, founded in 2002 to address the need for high-quality medical software. The company specializes in developing integrated solutions that manage patient and financial data for Management Service Organizations, healthcare providers, and insurance providers. Its key products include SFS/CareBook, which enables the tracking of subscriber services and funding data from various insurance providers, and EMR / Trinity, a web-based platform for electronic health records, practice management, care coordination, and patient engagement. DataLink's offerings promote collaboration among stakeholders in the healthcare continuum by providing real-time data aggregation, EHR connectivity, and dynamic reporting tools. The company's intelligent, data-driven solutions aim to reduce healthcare costs, enhance quality of care, ensure accurate risk adjustments, and simplify navigation through the healthcare system.

Arabesque

Series A in 2019
Established independently in 2013 following a management buyout from Barclays Bank PLC, Arabesque’s mission is to enable its clients and market stakeholders to implement sustainability in their investments and financial decision-making. Arabesque Holding Ltd (the parent company of Arabesque Group) is the holding company which manages three businesses: Arabesque Asset Management, Arabesque S-Ray and Arabesque AI. The Group’s businesses operate in an integrated manner, each bringing complementary capabilities to clients. Arabesque Asset Management manufactures sustainable investment products, Arabesque S-Ray researches and publishes non-financial data on over 8,000 listed companies as well as generating scores that independently assess company level ESG performance, and Arabesque AI manages an artificial intelligence engine that can deliver market-beating active fund management strategies. The Arabesque Group and its subsidiaries hold strategic partnerships with shareholders including Accenture, Allianz X, Commerz Real AG, DWS Group, Helaba Digital, and the German federal state of Hessen.

Nutraceutical International Corp.

Private Equity Round in 2019
Nutraceutical International Corp. manufactures, markets, distributes, and retails branded nutritional supplements and other natural products in the United States and internationally.

ESG Book

Series A in 2019
Arabesque S-Ray GmbH is a global financial services company that focuses on advisory and data solutions by combining big data and environmental, social and governance (ESG) metrics to assess the performance and sustainability of publicly listed companies worldwide. With offices in London, Frankfurt, Singapore, and Boston, S-Ray empowers investors, corporates and other stakeholders across the world to make more sustainable decisions. The firm’s evolution is a story of partnership between leaders in finance, mathematics, and sustainability working together to accelerate the transition to a more sustainable future. Arabesque S-Ray provides increased transparency into a company’s long- and short-term risks and opportunities by analysing its corporate DNA through a range of sustainability lenses. The company adopts a quantitative approach to analyse ESG data on thousands of companies worldwide, empowering clients to make better informed decisions. S-Ray systematically processes a diverse set of data sources, combining over 250 ESG long-term metrics with news and NGO signals from over 30,000 sources to provide more dynamic and responsive daily scores. The proprietary methodology of S-Ray utilizes big data technology to minimize human bias, and leverages an ever-expanding and diverse range of sources to create quantitative metrics by which to judge company performance.

Neo Technologies

Private Equity Round in 2018
At Neo Technologies, we are committed to providing our clients with leading client interfaces and administrative tools that would redefine how investment services are delivered and administered by incorporating industry best practices and in cooperation with first-rate advisors. Neo’s platform-as-a-service is enabling banks and financial institutions to deliver on retail & affluent wealth opportunities by launching leading services in a fraction of the time, cost and resources all within a compliant framework using our turn-key technology.

Skyline AI

Series A in 2018
Skyline AI Ltd develops an artificial intelligence based forecasting platform for the commercial real estate market. Its platform mines, synthesizes, and utilizes live data and helps in predicting future rent and disposition prices, identifying market trends, identifying properties with ideal risk-reward ratios, locating and exploiting market anomalies, and capturing arbitrage between asking price and market price. The company was incorporated in 2014 and is based in Tel Aviv-Yafo, Israel.

MEDecision

Series C in 2003
MEDecision offers collaborative healthcare management solutions aimed at enhancing the operations of health plans and care delivery organizations. The company specializes in digital care management services that integrate various modular healthcare management and data analysis tools. By connecting the healthcare ecosystem with essential data and insights, MEDecision enables its clients to foster meaningful consumer engagement and improve experiences. Additionally, these solutions are designed to create operational efficiencies that can lower costs and promote more effective care delivery.

RealNames

Series D in 2000
RealNames is an online platform specializing in internet naming solutions and navigation systems, enhancing the way users interact with the web. Founded in 1996 by Keith Teare and based in San Carlos, California, with additional offices in major cities worldwide, RealNames simplifies internet navigation through its keyword-based naming system for the HTTP protocol. This system is utilized by a diverse range of clients, including companies, advertising agencies, internet service providers, and search engines. In addition to its naming solutions, RealNames offers an ad-free email service that is compatible with webmail and mobile devices, providing users with secure storage, support, and a seamless communication experience.

ViaCell

Venture Round in 2000
ViaCell is a biotechnology company focused on the area of women’s health. The company develops ViaCord, which enables families preserve their baby’s umbilical cord blood at the time of birth for possible future medical use; and ViaCyte, to broaden reproductive choices for women through the cryopreservation of human unfertilized eggs. ViaCell is based in Boston, Massachusetts.

MEDecision

Series B in 2000
MEDecision offers collaborative healthcare management solutions aimed at enhancing the operations of health plans and care delivery organizations. The company specializes in digital care management services that integrate various modular healthcare management and data analysis tools. By connecting the healthcare ecosystem with essential data and insights, MEDecision enables its clients to foster meaningful consumer engagement and improve experiences. Additionally, these solutions are designed to create operational efficiencies that can lower costs and promote more effective care delivery.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.